ConductScience.org, home

Paper ยท 37561981

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.

Pappas L and 30 others. JCO Precis Oncol, 2023. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. Papers, record 37561981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37561981

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
PubMed
Journal
JCO Precis Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2024-02-10
PubMed

Authors31

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pappas LLeontioshttps://orcid.org/0000-0003-2276-8398
2Baiev IIslam
3Reyes SStephanie
4Bocobo AGAndrea Grace
5Jain AApurvahttps://orcid.org/0000-0003-0801-5939
6Spencer KKristenhttps://orcid.org/0000-0001-5577-3439
7Le TMTri Minh
8Rahma OEOsama Ehttps://orcid.org/0000-0001-7302-5805
9Maurer JJordan
10Stanton JJen

1 to 10 of 31Source PubMed

See all 31 authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholangiocarcinomaMajor topic
Bile Duct NeoplasmsMajor topic
Humans
Young Adult
Adolescent
Middle Aged
Retrospective Studies
Bile Ducts, Intrahepatic
Biology

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 CA248473NCI NIH HHSUnited StatesK08CA248473PubMed and NIHNIH RePORTER
P50 CA127003NCI NIH HHSUnited StatesP50CA127003PubMed and NIHNIH RePORTER
R37 CA225655NCI NIH HHSUnited StatesR37CA225655PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,317,994Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.J Am Coll Surg2009https://conductscience.org/library/papers/19317994PubMed
228,376,186Colorectal Cancer Incidence Patterns in the United States, 1974-2013.J Natl Cancer Inst2017https://conductscience.org/library/papers/28376186PubMed
324,445,538Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.Nat Commun2014https://conductscience.org/library/papers/24445538PubMed
427,655,244Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.BMC Gastroenterol2016https://conductscience.org/library/papers/27655244PubMed
528,122,072Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.JAMA Surg2017https://conductscience.org/library/papers/28122072PubMed
628,024,947Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.J Mol Diagn2017https://conductscience.org/library/papers/28024947PubMed
733,692,336Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.Cell Death Dis2021https://conductscience.org/library/papers/33692336PubMed
830,156,052Breast cancer in adolescents and young adults.Pediatr Blood Cancer2018https://conductscience.org/library/papers/30156052PubMed
921,120,307Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients.Clinics (Sao Paulo)2010https://conductscience.org/library/papers/21120307PubMed
1030,854,646Clinical and molecular characterization of early-onset colorectal cancer.Cancer2019https://conductscience.org/library/papers/30854646PubMed

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42,948,669Early-onset biliary tract cancers: clinical and molecular insights.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42948669PubMed
42,787,855Care delivery among patients with early-onset versus average-onset cholangiocarcinoma: a nationwide retrospective analysis.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42787855PubMed
42,444,838Survival outcomes and prognostic factors in de novo advanced biliary tract cancer: insights from a Saudi multicenter cohort.Front Oncol2026https://conductscience.org/library/papers/42444838PubMed
42,442,510Molecular Subtypes of Cholangiocarcinoma and Their Translational Implications.Gastroenterology2026https://conductscience.org/library/papers/42442510PubMed
42,426,481Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic Cholangiocarcinoma.Ann Surg Oncol2026https://conductscience.org/library/papers/42426481PubMed
42,223,137Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.J Clin Oncol2026https://conductscience.org/library/papers/42223137PubMed
42,145,505Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis.Front Public Health2026https://conductscience.org/library/papers/42145505PubMed
42,086,664Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.NPJ Precis Oncol2026https://conductscience.org/library/papers/42086664PubMed
41,994,026Clinical and molecular characteristics of early-onset pancreatic and biliary cancers.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/41994026PubMed
41,850,249Early-Onset Digestive System Cancers: Risk Factors and Clinicopathological and Molecular Features Across Organ Sites.Cancer Sci2026https://conductscience.org/library/papers/41850249PubMed

1 to 10 of 18

See all 18 cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37561981

GET https://conductscience.org/api/papers/v1/37561981/authors?page=2